Actively Recruiting

Phase 4
Age: 18Years +
All Genders
Healthy Volunteers
NCT06250088

Emdogain Adjunctive to Autotransplantation

Led by Universidad Complutense de Madrid · Updated on 2024-05-09

20

Participants Needed

1

Research Sites

102 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this randomized clinical trial is to compare the adjunctive use of enamel matrix derivatives in the treatment of tooth autotransplantation in terms of clinical attachment level. The main question it aims to answer. What is the benefit, in terms of clinical attachment level and probing depths, of using enamel matrix derivatives adjunctive to tooth autotransplantation? Participants will be subjected to a digitally guided surgery of tooth autotransplantation. The protocol of the test group will be supplemented with the application of enamel matrix derivatives before the placement of the transplanted tooth into the surgically produced alveolus.

CONDITIONS

Official Title

Emdogain Adjunctive to Autotransplantation

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients 18 years or older capable of providing informed consent
  • Presence of teeth deemed unrestorable and needing replacement
  • Presence of a viable, healthy, periodontally stable, and nonfunctional tooth suitable for autotransplantation (e.g., third molar)
  • Periodontally healthy individuals or those with stable periodontal conditions after therapy
Not Eligible

You will not qualify if you...

  • Clinical attachment loss of donor teeth less than 6 mm
  • Compromised general health or systemic diseases affecting therapy outcome (e.g., uncontrolled diabetes, bone disorders)
  • Pregnant or nursing women
  • Chronic use of corticosteroids, NSAIDs, or immune-modulator drugs
  • Use of medications affecting bone metabolism (e.g., bisphosphonates)
  • Chronic oral mucosa diseases
  • Severe bruxism or clenching habits
  • Smoking more than 10 cigarettes per day
  • Non-compliance with oral hygiene (plaque index above 25% after therapy)
  • Inability to attend study procedures and follow-up visits

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Universidad Complutense de Madrid

Madrid, Spain, 28003

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here